Your browser doesn't support javascript.
loading
Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.
Slomp, Anne; Moesbergen, Laura M; Gong, Jia-Nan; Cuenca, Marta; von dem Borne, Peter A; Sonneveld, Pieter; Huang, David C S; Minnema, Monique C; Peperzak, Victor.
Afiliação
  • Slomp A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Moesbergen LM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Gong JN; Cancer and Hematology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Cuenca M; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • von dem Borne PA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Sonneveld P; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Huang DCS; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands; and.
  • Minnema MC; Cancer and Hematology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Peperzak V; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Blood Adv ; 3(24): 4202-4214, 2019 12 23.
Article em En | MEDLINE | ID: mdl-31856269

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 1 / Amplificação de Genes / Resistencia a Medicamentos Antineoplásicos / Proteína de Sequência 1 de Leucemia de Células Mieloides / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 1 / Amplificação de Genes / Resistencia a Medicamentos Antineoplásicos / Proteína de Sequência 1 de Leucemia de Células Mieloides / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda